Asia-Pacific

The Money Is Moving Into Cancer Screening. The Evidence Still Has to Catch Up.

In Australia, Cancer Medicine Delays Cost More Than Time

Cardiac rehab saves lives. Health systems still treat it like optional aftercare

Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.

Diphtheria Came Back. Remote Communities Are Carrying the Cost.

Bird Flu Reached Australia. Now Preparedness Has to Deliver.

India’s emergency price-cap rise for cisplatin and carboplatin exposes a blunt oncology truth

AMR Stewardship Starts Before the Antibiotic Is Prescribed

China’s PD-1/VEGF Bet Challenges the Lung Cancer Backbone
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
